In cervical cancer, Yang and colleagues discovered that ZNF217 is targeted by miR-3163 and that the lncRNA CTBP1 antisense RNA 2 (CTBP1-AS2) regulates cancer progression after miR-3163 sponging to upregulate ZNF217 [93]. Here, ZNF217 is linked to cervical cancer.